Author

Hanna Hranovska

Observed names: A.I. Hranovska, H. Hranovska, H.I. Hranovska, Hanna I. Hranovska

Institution: State Organization «Grigoriev Institute for Medical Radiology and Oncology of the National Academy of Medical Sciences of Ukraine»

Observed institutions: Ivano-Frankivsk National Medical University, National Academy of Medical Sciences of Ukraine, State Organization «Grigoriev Institute for Medical Radiology and Oncology of the National Academy of Medical Sciences of Ukraine», V. N. Karazin Kharkiv National University

ORCID: 0000-0002-1238-5855

Observed ORCID: 0000-0002-1238-5855

OpenAlex ID: A5010467230

How to optimize and evaluate diversity in gynecologic cancer clinical trials: statements from the GCIG Barcelona Meeting

2024 · Jalid Sehouli, Jolijn Boer, et al. · International Journal of Gynecological Cancer · 10

Evaluation of Hormonal Function in Women With Cervical Insufficiency and Infertility in the History

2021 · Oksana M. Perkhulyn, Lyudmyla V. Pakharenko, et al. · Wiadomości Lekarskie · 4

Medical informatics methods in the assessment of follow-up data and prediction of oncological outcomes of multimodal treatment for early-stage cervical cancer

2026 · Ye.B. Radzishevska, O.M. Sukhina, et al. · Український радіологічний та онкологічний журнал · 1

Determination of risk factors for the occurrence of recurrences, metastases, and somatic complications after treatment of locally advanced cervical cancer using modern information technologies

2024 · Ye.B. Radzishevska, О.М. Sukhina, et al. · Український радіологічний та онкологічний журнал · 1

Risk factors for local and distant metastasis and survival characteristics of patients with locally advanced cervical cancer, revealed on the basis of analysis of historical data for the period 1998–2021

2024 · Ye.B. Radzishevska, О.М. Sukhina, et al. · Український радіологічний та онкологічний журнал · 1

Minimal Required Data Set For Gynecological Cancer Trials: The GCIG Statement From The Barcelona Meeting

2025 · Jolijn Boer, Alison Brand, et al. · International Journal of Gynecological Cancer

655 Retrospective analysis of the clinical outcome of uterine cervix cancer patients with operable disease

2024 · Vladyslav Sukhin, Olexandr Mikhanovskyj, et al. · International Journal of Gynecological Cancer

Therapeutic pathomorphosis of stage IB–IIA cervical cancer cells after various regimens of preoperative HDR brachytherapy

2023 · V.S. Sukhin, H.I. Hranovska, et al. · Український радіологічний та онкологічний журнал

55P Our experience of the hormone therapy in uterine sarcoma patients

2023 · V. Kovalchuk, M. Krasnoselskiy, et al. · ESMO Open

Use of 3D planning of HDR brachytherapy in patients with cervical cancer

2022 · K.V. Nemaltsova, O.M. Sukhina, et al. · Український радіологічний та онкологічний журнал

171 Dynamic dose fractionation of HDR-brachytherapy at preoperative irradiation of cervical cancer patients

2021 · V. Sukhin, H. Hranovska, et al. · International Journal of Gynecological Cancer

Works count: 11

Citation count: 17

H-index: 2

I10-index: 1